Aptose Biosciences Inc

NASDAQ:APTO   3:59:56 PM EDT
3.71
-0.05 (-1.33%)
4:03:15 PM EDT: $3.89 +0.18 (+4.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aptose Biosciences Inc Stock, NASDAQ:APTO

251 Consumers Road, Suite 1105, Toronto, Ontario M2J 4R3
Canada
Phone: +1.647.479.9828
Number of Employees: 39

Description

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.